Abstract In the United States, 100,000–300,000 patients die from venous thromboembolism
(VTE) each year, with more than 500,000 people related hospitalizations. While in Europe …

Objectives Recent research suggests that rheumatoid arthritis increases the risk of venous
thromboembolism. This study compared the risk of venous thromboembolism in patients with …

Objectives To assess incidence rates (IRs) of VTE in patients with rheumatoid arthritis (RA)
on different DMARDs and DMARD switchers. Methods Adults with RA on a DMARD …

Background Inflammatory arthritides including rheumatoid arthritis (RA), psoriatic arthritis
(PsA) and ankylosing spondylitis (AS) are associated with increased risk of cardiovascular …

Objectives Past studies have reported conflicting rates of venous thrombotic events (VTEs)
in rheumatoid arthritis (RA). The current study aimed to compare (1) the rates of VTEs in …

Context Recent reports suggest that rheumatoid arthritis (RA) may be a risk factor for venous
thromboembolism (VTE), particularly in conjunction with hospitalization. Using …

Introduction We performed a meta-analysis to investigate the risk of deep vein thrombosis
(DVT) and/or pulmonary embolisms (PEs) in patients with inflammatory arthritis, vasculitis …

Objective To examine the comparative effects of biologic disease-modifying antirheumatic
drugs (bDMARD) and tofacitinib against conventional synthetic DMARD (csDMARD) on …

Purpose Health insurance claims databases provide an opportunity to study uncommon
events, such as venous thromboembolism (VTE), in large patient populations. This study …

Background Thrombotic events, such as venous thromboembolism (VTE) are a major health
complication linked to rheumatoid arthritis (RA). We performed a meta-analysis to evaluate …